Kiniksa Pharmaceuticals International (KNSA) Return on Capital Employed Growth (3y) (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 480.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,902.00 |
| 10 | Kiniksa Pharmaceuticals International | 4.82 Bn | 4.36 Bn | 193.47 Mn | 933.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 933.00 |
| Dec 31, 2025 | 1,053.00 |
| Sep 30, 2025 | 1,840.00 |
| Jun 30, 2025 | 6,265.00 |
| Mar 31, 2025 | 6,878.00 |
| Dec 31, 2024 | 6,935.00 |
| Sep 30, 2024 | 6,908.00 |
| Jun 30, 2024 | 6,637.00 |
| Mar 31, 2024 | 5,346.00 |
| Dec 31, 2023 | 4,125.00 |
| Sep 30, 2023 | 4,075.00 |
| Jun 30, 2023 | 6,361.00 |
| Mar 31, 2023 | 6,488.00 |
| Dec 31, 2022 | 7,309.00 |
| Sep 30, 2022 | 5,626.00 |
| Jun 30, 2022 | -210.00 |
| Mar 31, 2022 | -1,832.00 |
| Dec 31, 2021 | -4,206.00 |
| Sep 30, 2021 | -4,539.00 |